In breast cancer, circulating levels of IL-10+ and TGF-β+ NK cells are increased, which inhibits the production of the NK cell effectors, IFN-γ and CD107a, and promotes the migration and invasion of breast-cancer cells [9]. This evidence concerns the gene IL10 and breast carcinoma.